The chief executive of the UK’s biggest tech company has said that advances in artificial intelligence will deliver a cure for cancer within the next few decades.
Rene Haas, who heads Arm Holdings, one of the world’s leading chip designers, claimed that AI would be able to solve the problem of modelling DNA markers impacted by cancer, which is currently “too complex” for humans or current AI systems.